[1] |
ZHONG N, WANG C, YAO W, et al. Prevalence of chronic obstructive pulmonary disease in China:a large,population-based survey[J]. Am J Respir Crit Care Med, 2007, 176(8):753-760.
DOI
URL
|
[2] |
林泽辉, 许银姬. 慢性阻塞性肺疾病急性加重患者住院死亡结局预测模型研究[J]. 临床肺科杂志, 2020, 25(8):1175-1179.
|
[3] |
SIVAPALAN P, INGEBRIGTSEN T S, RASMUSSEN D B, et al. COPD exacerbations: the impact of long versus short courses of oral corticosteroids on mortality and pneumonia:nationwide data on 67 000 patients with COPD followed for 12 months[J]. BMJ Open Respir Res, 2019, 6(1):e000407.
DOI
URL
|
[4] |
GUTTA L, M S, AHMED T. NLR and PLR ratios-accessible and affordable predictors of disease severity in COPD[J]. J Assoc Physicians India, 2022, 70(4):11-12.
|
[5] |
喻瑞, 黎友伦. NLR、PLR及RCI对慢性阻塞性肺疾病严重程度的预测价值[J]. 重庆医学, 2022, 51(11):1902-1907.
|
[6] |
AHIN F, KOAR A F, ASLAN A F, et al. Serum biomarkers in patients with stable and acute exacerbation of chronic obstructive pulmonary disease: a comparative study[J]. J Med Biochem, 2019, 38(4):503-511.
DOI
PMID
|
[7] |
卓超洲, 沈观乐, 余瑞林, 等. NLR, PLR在慢性阻塞性肺疾病合并肺间质纤维化中的临床应用价值[J]. 临床肺科杂志, 2019, 24(12):2161-2165.
|
[8] |
曹亮, 赵建清, 钱海红, 等. 静脉血平均血小板体积对慢性阻塞性肺疾病急性加重恢复期患者的诊断价值[J]. 山东医药, 2018, 58(17):72-74.
|
[9] |
中华医学会呼吸病学分会慢性阻塞性肺疾病学组. 慢性阻塞性肺疾病诊治指南(2013年修订版)[J]. 中华结核和呼吸杂志, 2013, 36(4):255-264.
|
[10] |
KOULENTI D, PARISELLA F R, XU E, et al. The relationship between ventilator-associated pneumonia and chronic obstructive pulmonary disease: what is the current evidence?[J]. Eur J Clin Microbiol Infect Dis, 2019, 38(4):637-647.
DOI
URL
|
[11] |
KICHLOO A, ALJADAH M, VIPPARLA N, et al. Optimal glucocorticoid dose and the effects on mortality, length of stay,and readmission rates in patients diagnosed with acute exacerbation of chronic obstructive pulmonary disease(AECOPD)[J]. J Investig Med, 2019, 67(8):1161-1164.
DOI
URL
|
[12] |
ZHANG H, LI J, YU X, et al. Effects of Chinese medicine on patients with acute exacerbations of COPD: study protocol for a randomized controlled trial[J]. Trials, 2019, 20(1):735.
DOI
PMID
|
[13] |
郭淑轶, 张建国. NT-proBNP与慢阻肺急性加重期患者预后的相关性研究[J]. 临床医学工程, 2021, 28(4):443-444.
|
[14] |
杨凤. 降钙素原、C反应蛋白联合检测在慢性阻塞性肺疾病急性加重期中的临床意义[J]. 中国全科医学, 2020, 23(S1):173-174.
|
[15] |
胡斯明, 徐晓, 徐国鹏, 等. PLR和NLR在慢性阻塞性肺疾病急性加重病情评估中的临床价值[J]. 中国实用医药, 2019, 14(33):7-10.
|
[16] |
张果果. 探讨PLR、NLP及C反应蛋白水平检测在慢阻肺急性加重诊断中的应用[J]. 数理医药学杂志, 2020, 33(11):1608-1610.
|
[17] |
EMAMI ARDESTANI M, ALAVI-NAEINI N. Evaluation of the relationship of neutrophil-to lymphocyte ratio and platelet-to-lymphocyte ratio with in-hospital mortality in patients with acute exacerbation of chronic obstructive pulmonary disease[J]. Clin Respir J, 2021, 15(4):382-388.
DOI
PMID
|
[18] |
KARADENIZ G, AKTOĞU S, ERER O F, et al. Predictive value of platelet-to-lymphocyte ratio in exacerbation of chronic obstructive pulmonary disease[J]. Biomark Med, 2016, 10(7):701-710.
DOI
PMID
|
[19] |
黄燕, 党傲, 张家春. 慢性阻塞性肺疾病患者血清中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值、降钙素原水平与急性加重风险的相关性研究[J]. 实用医院临床杂志, 2022, 19(1):161-164.
|
[20] |
HLAPI I, SOMBORAC-BAURA A, POPOVI- GRLE S, et al. Platelet indices in stable chronic obstructive pulmonary disease-association with inflammatory markers,comorbidities and therapy[J]. Biochem Med (Zagreb), 2020, 30(1):010701.
|
[21] |
LIU J, LIU J, ZOU Y. Relationship between neutrophil-lymphocyte ratio and short-term prognosis in the chronic obstructive pulmonary patients with acute exacerbation[J]. Biosci Rep, 2019, 39(5):BSR20190675.
DOI
URL
|
[22] |
EL-GAZZAR A G, KAMEL M H, ELBAHNASY O K M, et al. Prognostic value of platelet and neutrophil to lymphocyte ratio in COPD patients[J]. Expert Rev Respir Med, 2020, 14(1):111-116.
DOI
URL
|
[23] |
ARCHONTOGEORGIS K, VOULGARIS A, PAPANAS N, et al. Mean platelet volume and platelet distribution width in patients with obstructive sleep apnea syndrome and concurrent chronic obstructive pulmonary disease[J]. Clin Appl Thromb Hemost, 2018, 24(8):1216-1222.
DOI
URL
|
[24] |
张辉, 伍冬冬, 马东波, 等. 血小板平均体积与血小板计数比值预测老年人慢性阻塞性肺疾病急性加重期近期预后的临床价值[J]. 中华老年医学杂志, 2020, 39(6):627-631.
|
[25] |
包蕾, 王永, 刘亚玲, 等. 第一秒用力呼气容积联合BODE评分对慢性阻塞性肺疾病合并肺结核患者预后的预测价值[J]. 内科急危重症杂志, 2019, 25(1):41-44.
|